RECRUITING

Targeted Genomic Analysis of Blood and Tissue Samples From Patients With Cancer

Description

This research trial studies the use of targeted genomic analysis of blood and tissue samples from patients with cancer. Genomic sequencing is a laboratory method that is used to determine the entire genetic makeup of a specific organism or cell type. Genomic sequencing can be used to find changes in areas of the genome that may be important in the development of cancer. It may also help doctors improve ways to diagnose and treat patients with rare cancers with poor prognosis or lack of effective therapy.

Conditions

Malignant Neoplasm
Talk to us

Related Conditions:

Malignant Neoplasm

Study Overview

On this page

Study Details

Study overview

This research trial studies the use of targeted genomic analysis of blood and tissue samples from patients with cancer. Genomic sequencing is a laboratory method that is used to determine the entire genetic makeup of a specific organism or cell type. Genomic sequencing can be used to find changes in areas of the genome that may be important in the development of cancer. It may also help doctors improve ways to diagnose and treat patients with rare cancers with poor prognosis or lack of effective therapy.

Targeted Genomic Analysis of Human Cancers

Targeted Genomic Analysis of Blood and Tissue Samples From Patients With Cancer

Condition
Malignant Neoplasm
Intervention / Treatment

-

Contacts and Locations

Brick

Ocean Medical Center, Brick, New Jersey, United States, 08724

Holmdel

Bayshore Community Hospital, Holmdel, New Jersey, United States, 07733

Jersey City

RWJBarnabas Health - Jersey City Medical Center, Jersey City, Jersey City, New Jersey, United States, 07302

Manahawkin

Southern Ocean County Medical Center, Manahawkin, New Jersey, United States, 08050

Morristown

Morristown Medical Center, Morristown, New Jersey, United States, 07960

Neptune

Jersey Shore Medical Center, Neptune, New Jersey, United States, 07753

New Brunswick

Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States, 08903

Red Bank

Riverview Medical Center/Booker Cancer Center, Red Bank, New Jersey, United States, 07701

Red Bank

Riverview Medical Center, Red Bank, New Jersey, United States, 07701

Summit

Overlook Hospital, Summit, New Jersey, United States, 07902

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Karnofsky/Lansky performance score \>= 30
  • * A signed written informed consent
  • * Evaluation in surgical/medical/radiation oncology/radiology clinic, with a history of biopsy-confirmed diagnosis of cancer of rare histology and/or poor prognosis with standard therapy; priority will be given to rare cancers with poor prognosis and lack of effective standard therapy; study principal investigator (PI) or designee will review and approve each case before enrollment
  • * Paraffin blocks of the patient's tumor tissue are available and accessible for analysis
  • * Karnofsky/Lansky performance score \< 30
  • * Life expectancy \< 3 months

Ages Eligible for Study

1 Year to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Rutgers, The State University of New Jersey,

Shridar Ganesan, PRINCIPAL_INVESTIGATOR, Rutgers Cancer Institute of New Jersey

Study Record Dates

2030-05